Literature DB >> 34153302

Circulating α-klotho regulates metabolism via distinct central and peripheral mechanisms.

Taylor Landry1, Daniel Shookster1, Hu Huang2.   

Abstract

Emerging evidence implicates the circulating α-klotho protein as a prominent regulator of energy balance and substrate metabolism, with diverse, tissue-specific functions. Despite its well-documented ubiquitous role inhibiting insulin signaling, α-klotho elicits potent antidiabetic and anti-obesogenic effects. α-Klotho facilitates insulin release and promotes β cell health in the pancreas, stimulates lipid oxidation in liver and adipose tissue, attenuates hepatic gluconeogenesis, and increases whole-body energy expenditure. The mechanisms underlying α-klotho's peripheral functions are multifaceted, including hydrolyzing transient receptor potential channels, stimulating integrin β1➔focal adhesion kinase signaling, and activating PPARα via inhibition of insulin-like growth factor receptor 1. Moreover, until recently, potential metabolic roles of α-klotho in the central nervous system remained unexplored; however, a novel α-klotho➔fibroblast growth factor receptor➔PI3kinase signaling axis in the arcuate nucleus of the hypothalamus has been identified as a critical regulator of energy balance and glucose metabolism. Overall, the role of circulating α-klotho in the regulation of metabolism is a new focus of research, but accumulating evidence identifies this protein as an encouraging therapeutic target for Type 1 and 2 Diabetes and obesity. This review analyzes the new literature investigating α-klotho-mediated regulation of metabolism and proposes impactful future directions to progress our understanding of this complex metabolic protein.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Energy balance; Fibroblast growth factors; Metabolism; Obesity; α-Klotho

Mesh:

Substances:

Year:  2021        PMID: 34153302      PMCID: PMC8277751          DOI: 10.1016/j.metabol.2021.154819

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   13.934


  130 in total

1.  Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.

Authors:  Ci-Di Chen; Sonia Podvin; Earl Gillespie; Susan E Leeman; Carmela R Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

2.  Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding.

Authors:  Allison W Xu; Linda Ste-Marie; Christopher B Kaelin; Gregory S Barsh
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

3.  Klotho converts canonical FGF receptor into a specific receptor for FGF23.

Authors:  Itaru Urakawa; Yuji Yamazaki; Takashi Shimada; Kousuke Iijima; Hisashi Hasegawa; Katsuya Okawa; Toshiro Fujita; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Nature       Date:  2006-10-29       Impact factor: 49.962

4.  Plasma klotho and mortality risk in older community-dwelling adults.

Authors:  Richard D Semba; Anne R Cappola; Kai Sun; Stefania Bandinelli; Mansi Dalal; Candace Crasto; Jack M Guralnik; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-04-07       Impact factor: 6.053

5.  In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.

Authors:  Teruyo Nakatani; Bara Sarraj; Mutsuko Ohnishi; Michael J Densmore; Takashi Taguchi; Regina Goetz; Moosa Mohammadi; Beate Lanske; M Shawkat Razzaque
Journal:  FASEB J       Date:  2008-10-03       Impact factor: 5.191

6.  Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing.

Authors:  Brian Y H Lam; Irene Cimino; Joseph Polex-Wolf; Sara Nicole Kohnke; Debra Rimmington; Valentine Iyemere; Nicholas Heeley; Chiara Cossetti; Reiner Schulte; Luis R Saraiva; Darren W Logan; Clemence Blouet; Stephen O'Rahilly; Anthony P Coll; Giles S H Yeo
Journal:  Mol Metab       Date:  2017-03-01       Impact factor: 7.422

7.  Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.

Authors:  Hyo Jin Kim; Joongyub Lee; Dong-Wan Chae; Kyu-Beck Lee; Su Ah Sung; Tae-Hyun Yoo; Seung Hyeok Han; Curie Ahn; Kook-Hwan Oh
Journal:  BMC Nephrol       Date:  2019-04-03       Impact factor: 2.388

8.  Protective potential of klotho protein on diabetic retinopathy: Evidence from clinical and in vitro studies.

Authors:  Baolan Ji; Huili Wei; Yao Ding; Huimin Liang; Lu Yao; Hang Wang; Hua Qu; Huacong Deng
Journal:  J Diabetes Investig       Date:  2019-07-20       Impact factor: 4.232

9.  Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake.

Authors:  Ken-ichiro Nakajima; Zhenzhong Cui; Chia Li; Jaroslawna Meister; Yinghong Cui; Ou Fu; Adam S Smith; Shalini Jain; Bradford B Lowell; Michael J Krashes; Jürgen Wess
Journal:  Nat Commun       Date:  2016-01-08       Impact factor: 14.919

10.  CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms.

Authors:  Aoi Satoh; Song-Iee Han; Masaya Araki; Yoshimi Nakagawa; Hiroshi Ohno; Yuhei Mizunoe; Kae Kumagai; Yuki Murayama; Yoshinori Osaki; Hitoshi Iwasaki; Motohiro Sekiya; Morichika Konishi; Nobuyuki Itoh; Takashi Matsuzaka; Hirohito Sone; Hitoshi Shimano
Journal:  iScience       Date:  2020-02-21
View more
  1 in total

Review 1.  Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations.

Authors:  Gérald J Prud'homme; Mervé Kurt; Qinghua Wang
Journal:  Front Aging       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.